Trade PRAX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Praxis Precision Medicines, Inc. (PRAX) is trading at US$298.95, down 3.71% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$10.5B. Over the past 52 weeks, PRAX has traded between US$41.78 and US$392.70. On Syfe you can trade PRAX with $0 commission and add it to your watchlist.
| Previous close | US$310.47 |
|---|---|
| Market cap | US$10.5B |
| 52-week range | US$41.78 – US$392.70 |
| Volume | 819.08K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.
Year: 2020
Praxis Precision Medicines Could Be Approaching 'Perfect Trifecta,' Oppenheimer Says
Aug 17, 3:21 PM · MT Newswires
RBC Adjusts PT on Praxis Precision Medicines to $462 From $449, Keeps Outperform Speculative Risk Rating
Aug 7, 1:19 PM · MT Newswires
Deutsche Bank Adjusts Praxis Precision Medicines PT to $475 From $374, Maintains Buy Rating
Aug 7, 1:12 PM · MT Newswires
Wedbush Adjusts PT on Praxis Precision Medicines to $188 From $162, Maintains Underperform Rating
Aug 6, 3:58 PM · MT Newswires
Praxis Precision Medicines Q2 Net Loss Narrows; Shares Up Pre-Bell
Aug 6, 12:21 PM · MT Newswires
Praxis Precision Medicines, Inc. (PRAX) stock is trading at US$298.95, -3.71% from the previous close of US$310.47.
The market cap for Praxis Precision Medicines, Inc. (PRAX) stock is approximately US$10.5B.
The 52-week high for Praxis Precision Medicines, Inc. (PRAX) stock is US$392.70.
The 52-week low for Praxis Precision Medicines, Inc. (PRAX) stock is US$41.78.
Praxis Precision Medicines, Inc. (PRAX) does not currently pay a dividend.
Stay on top of PRAX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
